Lymphoma, Low-Grade Completed Phase 1 Trials for Fludarabine (DB01073)

Also known as: Low-Grade Lymphoma

Indication	Status	Phase
DBCOND0029914 (Lymphoma, Low-Grade)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00060684	Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's Lymphoma	Treatment	Dexamethasone (DB01234) Fludarabine (DB01073) Pixantrone (DB06193) Rituximab (DB00073)